U.S. regulators have barred seven doctors from conducting clinical trials of drugs and medical devices this year, as many as in the three previous years combined, after lawmakers complained about delays in discipline.
The Food and Drug Administration disqualifies researchers that the agency finds were involved in
misconduct, including falsifying results, during studies. Among those banned this year, according to the agency's Web site, was Maria Anne Kirkman Campbell, who pleaded guilty to fraud in 2003 in connection with a study on a Sanofi-Aventis antibiotic.
...
In February the FDA was found to have failed to complete disciplinary action against 12 researchers after proposing that they be disqualified from trials based on findings that they violated rules designed to protect patients and ensure accurate data. Cases remained unresolved for as long as a decade.
The agency relies on the results of clinical trials to determine whether drugs and medical devices are safe and effective enough to clear for sale. Delays in disciplining doctors who do not properly supervise the tests put patients at risk and threaten the validity of the studies, according to medical ethicists.
IHT